Beata I. W.
- Country
- Poland
- Department
- Dermatology
Research Overview
- A Phase 2b Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Ritlecitinib in Adult Participants with Chronic Spontaneous Urticaria
- A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of DT-101 in Adults with Major Depressive Disorder
- A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
Data & Insights
Has run more than one trial at 309 of 586 partner sites.
Specializations
Inflammatory Skin Conditions
The investigator specializes in treating various inflammatory skin disorders, with particular emphasis on atopic dermatitis and chronic hand eczema. Their research encompasses both pediatric and adult populations, investigating novel therapeutic approaches.
- Moderate to severe atopic dermatitis management
- Chronic hand eczema treatment innovations
- Topical and systemic therapy evaluation
Autoimmune Dermatological Conditions
The investigator focuses on treating complex autoimmune skin disorders, including psoriatic arthritis, plaque psoriasis, and alopecia areata. Their work includes evaluation of biological therapies and innovative treatment approaches.
- Pediatric and adult psoriasis management
- Advanced biological therapy applications
- Hair loss disorder treatments
Chronic Skin Disorders
The investigator demonstrates expertise in managing persistent skin conditions, particularly chronic spontaneous urticaria and acne vulgaris. Their research involves both traditional and emerging therapeutic options.
- Long-term urticaria management strategies
- Innovative acne treatments
- Novel topical therapy development
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.